BRCA1 and BRCA2 polymorphisms and intronic variants: which pathological role?

被引:0
|
作者
Tommasi, S. [1 ,2 ]
Pilato, B. [1 ,2 ]
Pinto, R. [1 ,2 ]
Lacalamita, R. [1 ,2 ]
Menolascina, F. [1 ,2 ]
Schitulli, F. [1 ,2 ]
Bruno, M. [1 ,2 ]
Paradiso, P. [1 ,2 ]
机构
[1] Natl Canc Inst Giovanni Paolo 2, Bari, Italy
[2] Natl Canc Inst Giovanni Paolo 2, Bari, Italy
来源
EJC SUPPLEMENTS | 2007年 / 5卷 / 08期
关键词
D O I
10.1016/S1359-6349(08)70090-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:33 / 34
页数:2
相关论文
共 50 条
  • [21] BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families
    Cherbal, Farid
    Salhi, Nadjet
    Bakour, Rabah
    Adane, Saida
    Boualga, Kada
    Maillet, Philippe
    DISEASE MARKERS, 2012, 32 (06) : 343 - 353
  • [22] Intronic alterations in BRCA1 and BRCA2:: Effect on mRNA splicing fidelity and expression
    Chen, XW
    Truong, TTN
    Weaver, J
    Bove, BA
    Cattie, K
    Armstrong, BA
    Daly, MB
    Godwin, AK
    HUMAN MUTATION, 2006, 27 (05) : 427 - 435
  • [23] Role of BRCA1 and BRCA2 mutations in pancreatic cancer
    Greer, Julia B.
    Whitcomb, David C.
    GUT, 2007, 56 (05) : 601 - 605
  • [24] The role of BRCA1 AND BRCA2 in hereditary breast cancer
    Christopoulou, Athina
    Spiliotis, John
    GENE THERAPY AND MOLECULAR BIOLOGY, 2006, 10A : 95 - 99
  • [25] Prediction of the functional impact of missense variants in BRCA1 and BRCA2 with BRCA-ML
    Steven N. Hart
    Eric C. Polley
    Hermella Shimelis
    Siddhartha Yadav
    Fergus J. Couch
    npj Breast Cancer, 6
  • [26] Prediction of the functional impact of missense variants in BRCA1 and BRCA2 with BRCA-ML
    Hart, Steven N.
    Polley, Eric C.
    Shimelis, Hermella
    Yadav, Siddhartha
    Couch, Fergus J.
    NPJ BREAST CANCER, 2020, 6 (01)
  • [27] Missense Polymorphisms in BRCA1 and BRCA2 and Risk of Breast and Ovarian Cancer
    Dombernowsky, Sarah Louise
    Weischer, Maren
    Freiberg, Jacob Johannes
    Bojesen, Stig Egil
    Tybjaerg-Hansen, Anne
    Nordestgaard, Borge Gronne
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (08) : 2339 - 2342
  • [28] The frequency and pathogenicity of BRCA1 and BRCA2 variants in the general Japanese population
    Masashi Idogawa
    Tasuku Mariya
    Yumi Tanaka
    Tsuyoshi Saito
    Hiroshi Nakase
    Takashi Tokino
    Akihiro Sakurai
    Journal of Human Genetics, 2024, 69 : 225 - 230
  • [29] Assessment of blind predictions of the clinical significance of BRCA1 and BRCA2 variants
    Cline, Melissa S.
    Babbi, Giulia
    Bonache, Sandra
    Cao, Yue
    Casadio, Rita
    de la Cruz, Xavier
    Diez, Orland
    Gutierrez-Enriquez, Sara
    Katsonis, Panagiotis
    Lai, Carmen
    Lichtarge, Olivier
    Martelli, Pier L.
    Mishne, Gilad
    Moles-Fernandez, Alejandro
    Montalban, Gemma
    Mooney, Sean D.
    O'Conner, Robert
    Ootes, Lars
    Ozkan, Selen
    Padilla, Natalia
    Pagel, Kymberleigh A.
    Pejaver, Vikas
    Radivojac, Predrag
    Riera, Casandra
    Savojardo, Castrense
    Shen, Yang
    Sun, Yuanfei
    Topper, Scott
    Parsons, Michael T.
    Spurdle, Amanda B.
    Goldgar, David E.
    HUMAN MUTATION, 2019, 40 (09) : 1546 - 1556
  • [30] BRCAIndica: a resource for ACMG/AMP classified BRCA1 and BRCA2 variants
    Vatsyayan, Aastha
    Anu, R. I.
    Mathur, Prerika
    Uchil, Divya
    Joshi, Ashish
    Dwivedi, Aradhana
    Sirohi, Bhawna
    Mathew, Aju
    Damodaran, Dileep
    Panda, Soumya Surath
    Kolluri, Spoorthy
    Ayillath, Shaji K.
    Amalnath, Deepak
    Shankar, Gomathi
    Pandhare, Kavita
    Scaria, Vinod
    FAMILIAL CANCER, 2025, 24 (01)